Black Diamond Therapeutics (BDTX) Operating Expenses (2018 - 2026)
Black Diamond Therapeutics' (BDTX) quarterly Operating Expenses came in at $11.3 million in Q1 2026, down 27.22% YoY from $15.5 million in Q1 2025, and down 36.06% on a QoQ basis from $17.6 million in Q4 2025.
Black Diamond Therapeutics (BDTX) Operating Expenses (2018 - 2026) Analysis & Trends
Black Diamond Therapeutics (BDTX) has 9 years of Operating Expenses data on file, last reported at $11.3 million in Q1 2026.
- Quarterly Operating Expenses fell 27.22% year-over-year to $11.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $53.3 million (down 28.02% YoY) and the FY2025 annual result came in at $57.5 million, down 27.04% from the prior year.
- Operating Expenses retreated to $11.3 million in Q1 2026, from $17.6 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $25.7 million in Q1 2022 to a low of $11.0 million in Q3 2025.
- A 5-year average of $19.2 million and a median of $20.2 million in 2024 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2024 — Operating Expenses climbed 10.47% — and 2025, when it tumbled 39.45%.
- Tracing BDTX's Operating Expenses over 5 years: stood at $21.9 million in 2022, then declined by 4.56% to $20.9 million in 2023, then slipped by 12.37% to $18.3 million in 2024, then declined by 3.64% to $17.6 million in 2025, then sank by 36.06% to $11.3 million in 2026.
- The last three Operating Expenses figures came in at $11.3 million (Q1 2026), $17.6 million (Q4 2025), and $11.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.35 Bn | 131.49 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 86.24 Bn | 78.25 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.08 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 58.83 Bn | 53.69 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | 1.06 Bn |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn | -784.57 Mn |
| 8 | Insmed | 27.50 Bn | 26.34 Bn | 358.27 Mn | 427.03 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.44 Bn | - | 541.02 Mn |
| 10 | Black Diamond Therapeutics | 125.35 Mn | 14.84 Mn | - | 12.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.06 Mn |
| Mar 31, 2026 | 11.26 Mn |
| Dec 31, 2025 | 17.61 Mn |
| Sep 30, 2025 | 10.98 Mn |
| Jun 30, 2025 | 13.42 Mn |
| Mar 31, 2025 | 15.47 Mn |
| Dec 31, 2024 | 18.28 Mn |
| Sep 30, 2024 | 18.13 Mn |
| Jun 30, 2024 | 22.13 Mn |
| Mar 31, 2024 | 20.25 Mn |
| Dec 31, 2023 | 20.86 Mn |
| Sep 30, 2023 | 24.01 Mn |
| Jun 30, 2023 | 20.03 Mn |
| Mar 31, 2023 | 21.56 Mn |
| Dec 31, 2022 | 21.85 Mn |
| Sep 30, 2022 | 22.12 Mn |
| Jun 30, 2022 | 23.17 Mn |
| Mar 31, 2022 | 25.68 Mn |
| Dec 31, 2021 | 26.08 Mn |
| Sep 30, 2021 | 35.36 Mn |